BCTXL — BRIACELL THERAPEUTICS CORP
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 10 SEC-registered investment managers reported holding BCTXL (BRIACELL THERAPEUTICS CORP) in their latest 13F filings, with a combined reported value of $2.53M across 2.96M shares. That is -12.3% by share count (-416.24K shares) versus the previous quarter, while reported value moved -26.2%. Ownership is concentrated: the five largest holders account for 75.9% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 4 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of BRIACELL THERAPEUTICS CORP (BCTXL) include Citadel Advisors, ARMISTICE CAPITAL, LLC, Cable Car Capital, LP, ranked by reported 13F value among the 16 institutional holders on this page.
BCTXL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 5 | 579.64K | $672.39K | -5.4% |
| Q2 2026 | 10 | 2.96M | $2.53M | -12.3% |
| Q1 2026 | 15 | 3.57M | $3.70M | — |
Over the 3 quarters shown, institutional share counts decreased 84% in aggregate (Q1 2026 → Q3 2026); the largest single-quarter swing was Q2 2026 (-12.3%).
Top Institutional Holders (Q3 2026) — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 195.00K | $226.20K | 0.03% | Hold | |
| 181.61K | $210.67K | 0.05% | Add | |
| 136.37K | $158.18K | 3.52% | Reduce | |
| 65.00K | $75.40K | 0.03% | Hold | |
| 1.67K | $1.94K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 895.86K | $716.78K | 0.00% | Reduce | |
| 536.60K | $477.57K | 0.01% | Hold | |
| 321.90K | $286.49K | 0.01% | Hold | |
| 300.00K | $267.00K | 0.31% | Hold | |
| 195.82K | $174.28K | 0.04% | Reduce | |
| 190.38K | $169.44K | 1.23% | Reduce | |
| 186.58K | $149.28K | 0.03% | Reduce | |
| 159.56K | $142.00K | 0.05% | Add | |
| 104.20K | $92.73K | 0.00% | Hold | |
| 65.00K | $57.85K | 0.02% | Hold |
Q1 2026 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.05M | $1.05M | 0.00% | New | |
| 536.60K | $552.75K | 0.01% | New | |
| 380.69K | $392.14K | 4.58% | New | |
| 321.90K | $331.59K | 0.12% | New | |
| 300.00K | $309.03K | 0.37% | New | |
| 300.00K | $300.00K | 0.08% | New | |
| 200.00K | $206.02K | 0.05% | New | |
| 125.40K | $125.40K | 0.00% | New | |
| 115.00K | $118.46K | 0.06% | New | |
| 104.20K | $107.33K | 0.00% | New | |
| 20.00K | $83.80K | 0.00% | New | |
| 65.00K | $66.96K | 0.03% | New | |
| 25.00K | $25.75K | 0.02% | New | |
| 23.89K | $23.89K | 0.00% | New | |
| 7.50K | $7.00K | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Hudson Bay Capital Management LP sold 125.40K sh · $125.40K
- BOOTHBAY FUND MANAGEMENT, LLC sold 20.00K sh · $83.80K
- LuminArx Capital Management LP sold 25.00K sh · $25.75K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 23.89K sh · $23.89K
- FNY Investment Advisers, LLC sold 7.50K sh · $7.00K
Fund Position History — shares by quarter (top 16 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|
| MYDA Advisors LLC | 195.00K | 195.82K | 200.00K |
| Warberg Asset Management LLC | 181.61K | 159.56K | 115.00K |
| SABBY MANAGEMENT, LLC | 136.37K | 190.38K | 380.69K |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 65.00K | 65.00K | 65.00K |
| UBS Group AG | 1.67K | — | — |
| Citadel Advisors | — | 895.86K | 1.05M |
| ARMISTICE CAPITAL, LLC | — | 536.60K | 536.60K |
| Cable Car Capital, LP | — | 321.90K | 321.90K |
| Empery Asset Management, LP | — | 300.00K | 300.00K |
| HEIGHTS CAPITAL MANAGEMENT, INC | — | 186.58K | 300.00K |
| Hudson Bay Capital Management LP | — | — | 125.40K |
| Clear Street Group Inc. | — | 104.20K | 104.20K |
| BOOTHBAY FUND MANAGEMENT, LLC | — | — | 20.00K |
| LuminArx Capital Management LP | — | — | 25.00K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | — | 23.89K |
| FNY Investment Advisers, LLC | — | — | 7.50K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold BCTXL?
As of 2026-Q2, 10 institutional funds reported holding BCTXL (BRIACELL THERAPEUTICS CORP) in SEC 13F filings, with a combined reported value of $2.53M.
How many shares of BCTXL do institutions own?
13F filers reported 2.96M shares of BCTXL, worth $2.53M in aggregate at the end of 2026-Q2.
Is institutional ownership of BCTXL rising or falling?
Share counts moved -12.3% versus the prior quarter — distribution.
Who are the top institutional holders of BCTXL?
The largest 13F holders are Citadel Advisors, ARMISTICE CAPITAL, LLC, Cable Car Capital, LP, Empery Asset Management, LP, MYDA Advisors LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of BRIACELL THERAPEUTICS CORP?
The major shareholders of BRIACELL THERAPEUTICS CORP (BCTXL) by reported 13F value are Citadel Advisors, ARMISTICE CAPITAL, LLC, Cable Car Capital, LP, Empery Asset Management, LP, MYDA Advisors LLC, among 16 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.